[HTML][HTML] Fructose 2, 6-bisphosphate. A new activator of phosphofructokinase.

SJ Pilkis, MR El-Maghrabi, J Pilkis, TH Claus… - Journal of Biological …, 1981 - Elsevier
SJ Pilkis, MR El-Maghrabi, J Pilkis, TH Claus, DA Cumming
Journal of Biological Chemistry, 1981Elsevier
A new activator of rat liver phosphofructokinase was partially purified from rat hepatocyte
extracts by DEAE-Sephadex chromatography. The activator, which eluted in the sugar
diphosphate region, was sensitive to acid treatment but resistant to heating in alkali. Mild
acid hydrolysis resulted in the appearance of a sugar monophosphate which was identified
as fructose 6-phosphate by gas chromatography/mass spectroscopy. These observations
suggest that the activator is fructose 2, 6-bisphosphate. This compound was synthesized by …
A new activator of rat liver phosphofructokinase was partially purified from rat hepatocyte extracts by DEAE-Sephadex chromatography. The activator, which eluted in the sugar diphosphate region, was sensitive to acid treatment but resistant to heating in alkali. Mild acid hydrolysis resulted in the appearance of a sugar monophosphate which was identified as fructose 6-phosphate by gas chromatography/mass spectroscopy. These observations suggest that the activator is fructose 2,6-bisphosphate. This compound was synthesized by first reacting fructose 1,6-bisphosphate with dicyclohexylcarbodiimide and then treating the cyclic intermediate with alkali. The structure of the synthetic compound was definitively identified as fructose 2,6-bisphosphate by 13C NMR spectroscopy. Fructose 2,6-bisphosphate had properties identical with those of the activator purified from hepatocyte extracts. It activated both the rat liver and rabbit skeletal muscle enzyme in the 0.1 microM range and was several orders of magnitude more effective than fructose 1,6-bisphosphate. Fructose 2,6-bisphosphate was not a substrate for aldolase or fructose 1,6-bisphosphatase. It is likely that this new activator is an important physiologic factor of phosphofructokinase in vivo.
Elsevier